Catalyst Wire Dossier Catalyst Wire Dossier

Belantamab Mafotidine

belantamab mafodotin · GSK
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Belantamab Mafotidine, covering 2025-01-15 to 2025-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

See pricing